Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 1:41:100644.
doi: 10.1016/j.ctro.2023.100644. eCollection 2023 Jul.

Realizing the value of complex medical technology: Demonstrating cost-effectiveness is not enough

C Hehakaya  1 , G W J Frederix  2 , J Rn van der Voort van Zyp  3 , D E Grobbee  1   3 , H M Verkooijen  3   4
Affiliations

Realizing the value of complex medical technology: Demonstrating cost-effectiveness is not enough

C Hehakaya et al. Clin Transl Radiat Oncol. .

Abstract

The main factors driving the value of medical treatments are proven effectiveness and cost-effectiveness. This is different for complex medical technologies that combine scientific disciplines, functions or tools in a single solution-oriented method. This short communication provides three recommendations to realize the value of complex medical technologies. It is important to engage stakeholders before technology implementation to promote its relevance from multiple perspectives, to explore opportunities for professional development and collaboration, and to demonstrate the societal effects over the entire life-cycle.

Keywords: Complex interventions; Evaluation; Implementation; Innovations; Stakeholders; Technologies.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Van Loon J., Grutters J., Macbeth F. Evaluation of novel radiotherapy technologies: What evidence is needed to assess their clinical and cost effectiveness, and how should we get it? Lancet Oncol. 2012;13(4):169–177. doi: 10.1016/S1470-2045(11)70379-5. - DOI - PubMed
    1. Phillips M., Harrington T., Srai J. Convergent innovation in emerging healthcare technology ecosystems: addressing complexity and integration. Technol Innov Manag Rev. 2017;7(9):44–54. doi: 10.22215/timreview/1105. - DOI
    1. Hehakaya C., Van der Voort van Zyp J.R., Lagendijk J.J.W., Grobbee D.E., Verkooijen H.M., Moors E.H.M. Problems and promises of introducing the magnetic resonance imaging linear accelerator into routine care: the case of prostate cancer. Front Oncol. 2020;10:1741. doi: 10.3389/fonc.2020.01741. - DOI - PMC - PubMed
    1. Hehakaya C., Sharma A.M., van der Voort Van Zijp J.R.N., Grobbee D.E., Verkooijen H.M., Izaguirre E.W., et al. Implementation of magnetic resonance imaging-guided radiation therapy in routine care: opportunities and challenges in the United States. Adv Radiat Oncol. 2022;7(5):100953. doi: 10.1016/j.adro.2022.100953. - DOI - PMC - PubMed
    1. Kerkmeijer L.G.W., Fuller C.D., Verkooijen H.M., Verheij M., Choudhury A., Harrington K.J., et al. The MRI-linear accelerator consortium: Evidence-based clinical introduction of an innovation in radiation oncology connecting researchers, methodology, data collection, quality assurance, and technical development. Front Oncol. 2016;6 doi: 10.3389/fonc.2016.00215. - DOI - PMC - PubMed

LinkOut - more resources